Vulnerabilities Found in Medfusion 4000 Syringe Infusion Pumps: A Call for Action in Cybersecurity
Recent cybersecurity alerts have highlighted significant vulnerabilities in medical devices, particularly the Medfusion 4000 Wireless Syringe Infusion Pump, a critical tool widely utilized in acute care settings. These vulnerabilities pose serious risks, as the devices can be hacked, potentially altering their intended operation. The U.S. Food and Drug Administration (FDA) recently recalled 465,000 pacemakers due to similar concerns, reinforcing the growing alarm surrounding connected medical technology.
Research conducted by independent cybersecurity expert Scott Gayou has uncovered eight distinct vulnerabilities within the Medfusion 4000. This device, manufactured by Smiths Medical—a Minnesota-based company—delivers precise medication doses in intensive care environments, including neonatal and pediatric units. The discovery of these security flaws prompts urgent considerations about the safety of connected medical devices.
Among the vulnerabilities identified, one particularly egregious exploit (CVE-2017-12725) has a CVSS score of 9.8, reflecting its high severity. This issue arises from the use of hard-coded usernames and passwords that establish an automatic wireless connection if the default settings remain unchanged. Essentially, this opens the door for remote attackers to gain unauthorized access to the device, significantly compromising patient safety.
The ICS-CERT (Industrial Control Systems Cyber Emergency Response Team) has warned that attackers could potentially compromise the communications and therapeutic modules of the pump. Some of the other high-severity vulnerabilities include a buffer overflow issue that could allow for remote code execution, a lack of authentication for FTP connections, and the presence of hard-coded credentials for the pump’s FTP server.
Furthermore, the absence of proper host certificate validation exposes the pump to man-in-the-middle (MitM) attacks, while lesser yet concerning vulnerabilities could lead to crashes of the device’s operational modules and expose passwords from configuration files. The devices affected run firmware versions 1.1, 1.5, and 1.6, with a patch—firmware version 1.6.1—expected to be released in January 2018.
In the interim, healthcare organizations are urged to implement defensive measures to mitigate these risks. Suggestions include assigning static IP addresses to the pumps, closely monitoring network traffic for anomalies, isolating the pumps on distinct networks, enforcing strong password policies, and regularly backing up device configurations. These steps aim to harden the devices against potential exploitation until more permanent solutions are available.
As concerns grow about the cybersecurity of medical devices, it is crucial for stakeholders to understand the risks that such vulnerabilities pose not only to the devices but also to patient safety. The MITRE ATT&CK framework highlights relevant tactics that attackers might exploit in such scenarios, including initial access, persistence, and privilege escalation, underscoring the need for heightened vigilance and enhanced security protocols in the healthcare sector.
Stakeholders must remain proactive in addressing cybersecurity risks associated with connected medical devices to safeguard both operational integrity and patient well-being. It is imperative that the industry collectively prioritizes robust cybersecurity measures to ensure the safe deployment of technology in healthcare environments.